Inventage Lab Inc

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:30

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeKRX

Market Capitalization324,043 mln

Float11.43 mln

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

-2.36

Borderline

Relative Strength

16 / 100

Significantly lagging

Debt / Equity

0.39

Low leverage

Pre-Tax Margin

-390%

Severely loss-making

ROE

-4.56

Negative

Business Description

Inventage Lab Inc. is a South Korean company that uses advanced microfluidic technology to create new drug delivery solutions. Founded in 2015 and headquartered in Seongnam-si, the company focuses on building platform technologies that improve how medicines are developed and delivered to patients.

Key Fundamentals

EPS-308

ROE-4.56

RPS199

ROIC-32.59

ROA-2.10

EBITDA, mln2,119

EV / EBITDA134

EV / EBIT-48.76

Revenue, mln2,473

EV / Revenue115

Quote Details

Last 23,950

Change 1150 (5.04%)

Open 22,950

Volume 70,236

Turnover 1,682,152,192

Average Volume 108,761

Financial Ratios

Pre-Tax Profit Margin-390

Current Ratio2.86

Price / Book3.09

Price / Tangible Book3.59

Debt / Equity0.39

Price / Sales126

Financial Strength

Altman Z-Score2.36

Piotroski F-Score 2 / 9

Beneish M-Score-2.36

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-8.59%	9 / 100
1 Month	-2.24%	68 / 100
2 Months	-28.83%	7 / 100
6 Months	-60.8%	5 / 100
1 Year	-36.3%	23 / 100